effects of semaglutide on chronic kidney disease semaglutide, empagliflozin and their combination renal diffusion-weighted MRI and total volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial π¨ Journal Club: FLOW Trial
Description
The goal isnt perfection or complete elimination of all favorite foods forever
The histopathological scoring of kidney injury was conducted in a blinded fashion as described in our previous report (40)
Your care plan will be personalized to fit your unique metabolic needs and health goals
Combination with finerenone for cardiorenal protection Recently, in FIDELIO-DKD [52], FIGARO-DKD [53] and their pooled meta-analysis FIDELITY [11], finerenone has also been shown to reduce cardiovascular and renal events in CKD patients with diabetes
Side effects are generally mild and temporary, occurring most often during dose escalation
